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Abstract.  An assay designed to measure the formation 
of functional transport vesicles was constructed by 
modifying a cell-free assay for protein transport be- 
tween compartments of the Golgi (Balch, W.  E., 
W.  G.  Dunphy, W.  A. Braell,  and J.  E.  Rothman. 
1984.  Cell.  39:405-416).  A  35-kD cytosolic protein 
that is immunologically and functionally indistinguish- 
able from otSNAP (soluble NSF attachment protein) 
was found to be required during vesicle formation. 
SNAP, together with the N-ethylmaleimide-sensitive 
factor (NSF) have previously been implicated in the 
attachment and/or fusion of vesicles with their target 
membrane.  We show that NSF is also required during 
the formation of functional vesicles. Strikingly,  we 
found that after vesicle formation,  the NEM-sensitive 
function of NSF was no longer required for transport 
to proceed through the ensuing  steps of vesicle attach- 
ment and fusion. In contrast to these functional tests 
of vesicle formation,  SNAP was not required for the 
morphological appearance of vesicular structures on 
the Golgi membranes.  If SNAP and NSF have a direct 
role in transport vesicle attachment and/or fusion, as 
previously suggested, these results indicate that these 
proteins become incorporated into the vesicle mem- 
branes during vesicle formation and are brought to the 
fusion site on the transport vesicles. 
T 
HE molecular mechanisms driving  protein transport 
are being illuminated  by the reconstitution  of trans- 
port in cell-free and semi-intact cell systems (reviewed 
by Goda and Pfeffer, 1989; Balch,  1989; Wattenberg,  1990), 
as well as by the application  of yeast molecular genetics (re- 
viewed by Schekman,  1985; Hicke and Schekman,  1990). 
One of the best characterized  cell-free assays  for protein 
transport measures the transit of the membrane glycoprotein 
(G protein) of vesicular stomatitis  virus (VSV) I from a cis- 
compartment of the Golgi apparatus  to a medial-compart- 
ment (Fries and Rothman,  1980; Balch et al.,  1984a).  This 
transport  is  measured  between two populations  of Golgi 
complex by a complementation assay. The Golgi apparatus 
in which the G protein originates  (termed donor) is deficient 
in an enzyme, normally localized to the medial-Golgi,  that 
adds  a  terminal  N-acetylglucosamine (GIcNAc)  to the G 
protein  oligosaccharides.  The target  Golgi apparatus  (ac- 
ceptor) does not initially  contain G protein,  but is replete 
with the GlcNAc transferase.  Therefore if G protein is trans- 
ported from donor to acceptor, the G protein oligosaccha- 
rides will be modified by the addition  of GIcNAc. This gly- 
cosylation event is used as a marker for transport from donor 
to acceptor. 
1. Abbreviations  used in this paper: NEM, N-ethylmaleimide; NSE N-ethyl- 
maleimide-sensitive factor; PF-1, priming factor 1; SNAP, soluble NSF at- 
tachment protein; VSV, vesicular stomatitis virus. 
A  variety  of evidence indicates  that  transport  between 
compartments of the Golgi apparatus  is mediated by small 
transport vesicles (Rothman et al.,  1984; Orci et al.,  1986, 
1989; reviewed in Rothman and Orci, 1992). Insight into the 
transport process therefore involves an understanding  of how 
these vesicles are produced, how they are targeted to their 
correct destination,  and how the membranes of the vesicles 
and the target compartment fuse to complete the delivery of 
the vesicle contents. An underpinning  for this understanding 
has been achieved through a variety of kinetic and morpho- 
logical studies which have defined and characterized several 
of the intermediate  stages of the vesicle production and fu- 
sion cycle (Balch et al., 1984b; Wattenberg et al., 1986; Orci 
et al.,  1989; Malhotra et al.,  1988). 
Perhaps the simplest of these observations is that there is 
a significant  lag time (7-10 min) before transport proceeds 
at a linear rate (Balch et al., 1984b). This corresponds to the 
time required for G protein to progress through  the inter- 
mediate steps of transport before arriving  at its destination. 
If donor membranes are preincubated with cytosol and ATP 
before the addition of acceptor membranes, there is a small 
but consistent reduction in the lag time of transport (Balch 
et al.,  1984b, also see Fig. 7 a of this report). This effect is 
termed donor priming.  A striking change in the morphology 
of the donor membranes occurs under the same conditions. 
Initially,  the Golgi  stacks have  relatively  few vesicles as- 
sociated with them.  After incubation,  a profusion of buds 
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branes. These new structures are coated with an apparently 
proteinaceous  material  (Orci  et  al.,  1986).  This  coat  is 
different from the clathrin coat best characterized in endo- 
cytic traffic. The kinetic effect of  donor preincubation and the 
morphological transformation, show identical requirements 
for ATP, cytosol, elevated temperature, and sensitivity to 
primaquine (Orci et al.,  1986, Hiebsch et al.,  1991). It is 
therefore reasonable to conclude that the altered kinetics 
conferred by donor preincubation are due, at least in part, 
to the formation of buds, structures which will eventually 
pinch off to form transport vesicles. 
Several proteins have been implicated in events leading up 
to the fusion of vesicles with their target once they have at- 
tached to the acceptor Golgi. The N-ethylmaleimide (NEM)- 
sensitive Factor (NSF) is presumed to act in such steps based 
on morphological evidence in both mammalian and yeast 
systems as well as biochemical data in a yeast system. In the 
absence of NSF, structures form which resemble attached 
but unfused transport vesicles (Glick and Rothman, 1987; 
Block et al., 1988; Malhotra et al., 1988; Orci et al., 1989). 
NSF is bound to membranes through three soluble proteins 
(the soluble NSF attachment proteins [SNAPs]) (Weidman 
et al., 1989; Clary et al., 1990; Clary and Rothrnan, 1990) 
and an as yet unidentified membrane receptor. Results using 
the yeast homologues of  NSF and SNAP, Secl 8p and Secl7p, 
respectively, indicate a somewhat different  role for these pro- 
teins. Mutations in Secl7 and Secl8 lead to the accumulation 
of free vesicles in yeast (Kaiser and Schekman, 1990).  This 
would suggest a role for SNAP and NSF in vesicle attach- 
ment, rather than fusion. Supporting this view are experi- 
ments using a broken cell assay in yeast which measures 
transport from the ER to the Golgi apparatus (Rexach and 
Schekman, 1991). In this assay also, free vesicles accumu- 
late at the nonpermissive temperature when extracts are pre- 
pared from cells with a temperature sensitive mutation in 
seclS.  It is as yet unresolved whether NSF and SNAPs are 
involved in vesicle attachment, vesicle fusion, or both. 
The  vesicle-producing  reactions  have  been  difficult to 
characterize biochemically. This is because the process is 
detected by the difference in kinetics of transport with or 
without donor preincubation (Balch et al., 1984b).  However 
the consumption of the buds/vesicles formed on the donor 
is not synchronous. Therefore, in the time that the buds/ 
vesicles from preincubated donor membranes go through the 
steps of  vesicle targeting and fusion, new vesicles are formed 
and can also complete the transport process. Thus at no time 
is the difference between a preincubated and control incuba- 
tion absolute. To alleviate this problem we have seized on the 
recent observation that the antimalarial drug primaquine is 
a selective inhibitor of donor priming (Hiebsch et al., 1991). 
Primaquine was  shown to inhibit donor but not acceptor 
function. Primaquine was also shown directly to inhibit the 
kinetic priming of donor membranes, but not reactions that 
occur after the donor preincubation, such as vesicle target- 
ing and fusion. Finally, an electron microscopic examination 
revealed that primaquine inhibited the formation of bud and 
vesicle structures in incubations of donor membranes. Here 
we use the ability of primaquine to inhibit vesicle formation 
to formulate an assay which specifically measures vesicle 
formation. Donor membranes are incubated under the con- 
ditions to be tested, and then primaquine is added along with 
acceptor membranes. The buds and vesicles formed during 
the first incubation will progress through the remainder of 
the transport pathway, but little new vesicle formation will 
be initiated. 
Materials and Methods 
Materials 
Unless otherwise specified all chemicals and biochemicals were from com- 
mercial  sources  and of the highest quality  available. 
Chemicals 
Primaquine, N-ethylmaleimide  and Tween 20 were from Sigma Chemical 
Co. (St. Louis, MO). UDP-[3H]-GIcNAc  (0.1 mCi/ml, 16.9 Ci/mMol) was 
from New England Nuclear (Boston, MA). 
Immunological Reagents 
Antiserum to SNAP was a generous gift of W. Whiteheart and J. Rothman 
(Sloan-Kettering  Cancer Institute, New York). The rabbit polyclonai  was 
raised against a peptide (154) common to r  and BSNAP and affinity purified 
against the same peptide. Purified SNAPs were also a gift from DIs. White- 
heart  and  Rothman.  Nitrocellulose  (0.45  btm) was  purchased  from 
Schleicher and Schuell, Inc. (Keene, NH). Nonfat dry milk (Carnation, Los 
Angeles,  CA)  was  used  for blocking immunoblots.  Immunoblots were 
stained with biotinylated goat anti-rabbit antiserum (Bethesda Research 
Laboratories, Gaithersburg, MD) and then avidin-conjugated alkaline phos- 
phatase (Vector Laboratories, Burlingame, CA). Alkaline phosphatase ac- 
tivity was measured using nitro blue tetrazolium and 5-bromo-4-chioro-3- 
indolyl phosphate (both from Promega Biotec,  Madison, WI). 
Methods 
Cell Culture and Preparation of CHO Cytosol and Membranes. Wild- 
type CHO cells and CHO mutant lecl (Stanley et al.,  1975) (ATCC), and 
VSV were grown and maintained as previously  described (Baich et al., 
1984a) as was growth, infection, and harvest of cells to produce donor and 
acceptor membranes. CHO cytosol was always prepared from lecl ceils and 
was desaited by gel filtration on Sephadex G-25 into 25 rnM Tris, 50 mM 
Kcl, pH g.0. 
Gel Electrophoresis and Iramunoblotting. SDS-gel electrophoresis was 
performed essentially  as described (Laemmli,  1970),  using  15%  acryl- 
amide separating gels. Minigel apparatus from BioRad Laboratories (Rich- 
mond, CA) were used for analysis of protein purification  and ll-cm gels, 
run on Hoeffer apparatus (Hoeffer Scientific Instruments, San Francisco, 
CA), were used for the immunoblot shown in Fig. 5. For immunoblots, gels 
were transferred to nitrocellulose overnight (0.25 mA) in a blotting buffer 
of 3 g/1 Trizma base,  14.4 g/l glycine  in 20% methanol. The blots were 
blocked with 5% dry milk in PBS/0.2%  Tween 20 (PBS/Tween) for 1 h at 
room temperature.  The primary, anti-SNAP antibody at a dilution of 1:30 
in PBS/Tween  was incubated with the blots for 1 h at room temperature. 
Blots were washed three times in PBS/Tween and then incubated with sec- 
ondary antibody, biotin-labeled goat anti-rabbit at 1:500, for 1 h at room 
temperature.  These blots were then washed three times in PBS/Tween and 
incubated fi3r 1 h with avidin-aikaline  phosphatase conjugate  (1:1,000 in 
PBS/Tween), washed three times with PBS/Tween and visualized with nitro 
blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. 
Primaquine-based Vesicle Production Assay. The assay is conducted in 
two stages. The first, vesicle production stage, consists of the cytosol frac- 
tion to be tested and 5 t~l of donor membranes in a buffer of 25 mM Tris, 
pH 7.5, 25 mM Kcl, 2.5 mM Mg (C2H302)2 and an ATP regenerating sys- 
tem (50/~M ATP, 250/~M UTP, 2 Mm creatine phosphate,  7.3 U/nil crea- 
tine phosphokinase) in a total volume of 40 td. When testing for the NEM- 
sensitive priming factor 5 ~tl (approximately  10/~g) of NEM-treated lecl 
cytosol is also added. For NEM treatment, cytosol is incubated for 15 rnin 
on ice with 0.4 raM NEM, then the NEM is quenched with 0.8 mM DTT. 
The vesicle production incubation  is for 20 min at 37~  The second incuba- 
tion, in which vesicle attachment and fusion occur,  is initiated by adding 
a cocktail consisting of (for each tube) 2.5/tl of crude lecl 1 cytosol, 5/~1 
of acceptor membranes, 2,5/~1 of 6 mM prinmquine, and 0.125/~Ci of UDP- 
3H-GIcNAc. 10/~1 of this mix was added to each tube and the incubation 
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after the donor preincubation resulted in loss of activity, so each tube was 
only briefly removed from the waterbath to add the second stage cocktail, 
and then immediately replaced. Immunoprecipitation of G protein, filtra- 
tion of the immunoprecipitates and liquid scintillation counting were per- 
formed as previously described (Wattenberg  et al.,  1990). 
Assay for NSl~binding Activity.  NSF-membrane binding assays  were 
performed using the two-stage assay previously described (Weidman et al., 
1989) as modified by Clary et al., (1990).  Each 25-#1 binding incubation 
(stage one) contained 1 #g of KCl-extracted CHO Golgi membrane protein, 
6 tag of ClIO NSF, and the indicated volumes of purified priming factor 1 
(PF-1)/SNAP (10 #g/mi) or bovine  brain cytosol (5.4 mg/ml) in NSF binding 
buffer (20 mM K+-HEPES,  pH 7.4,  1 mM EDTA,  100 mM KC1, 200 #M 
ATE 1 mM DTT, I% polyethylene  glycol, 200#g/ml soybean trypsin inhib- 
itor, and 0.2 M sucrose).  Incubations were performed in 1.5 ml microtubes 
that had been preincubated with 10 mg/ml BSA to block nonspeeific  sites. 
After  a  2-rain incubation at 0~  membrane-bound NSF  was  pelleted 
(12,000 g, 5 rain) and the pellets washed with NSF binding buffer (30 #1). 
The amount of NSF activity bound to the pellet was quantified in the second 
stage using the NSF-dependent Golgi transport reaction (assay conditions 
as described by Block et al.,  1988). 
The SNAP4ependent Salt-washed Golgi Assay.  This assay  was per- 
formed as previously described (Clary and Rothman, 1990).  This system 
uses various fractions of mammalian cytosol to reconstitute  transport with 
Golgi membranes that have been extracted with 1 M KC1 to remove most 
of  the peripheral membrane proteins (K-Golgi). Reconstitution is dependent 
on the addition of SNAP, NSE and three protein fractions (fractions 1, 3, 
and 4) prepared from bovine brain cytosol. Each assay contained KC1- 
extracted donor and acceptor Golgi membranes, &2 #g of fraction 1 pro- 
tein, 5.5 #g of fraction 3 protein, 3.5 #g of protein 4 protein, 6 ng of  purified 
CHO NSF, and the indicated volumes of PF-1/SNAP (10 #g/ml) or bovine 
brain cytosol (5.4 mg/ml) in a 25-#1 reaction mixture.  The concentrations 
of UDP-[3H]-GIcNAc,  salts, ATP regenerating system, and palmitoyl CoA 
in the reaction mixture and the conditions of the incubation were exactly 
as described (Clary and Rothman, 1990). 
Purification of  PF-i. Brain cytosoi was prepared from frozen bovine calf 
brain (Pel Freeze, Rogers, AR). 1 kg of brain was thawed in 2 1 of breaking 
buffer (100 mM Tris, ph 8.0, 500 mM KCI, 250 mM sucrose,  1 mM DTT, 
0.5 mM PMSE  l0 #g/ml leupeptin, 10 #M pepstatin, 1 mM 1,10 phenan- 
throline, 1 mM metabisulfite.) Homogenization was accomplished by two 
30-s bursts in a Waring Blender OVaring Products, New Hartford, CN). The 
homogenate was  centrifuged for 20 rain at 8,000  rpm in a  GSA rotor 
(Dupont/Sorvall Instruments Div., New Town, CT). The resulting superna- 
tant was centrifuged for 1 h in either a 45Ti rotor (Beckman Instruments, 
Inc., Palo Alto, CA) at 44,000 rpm or 50.2 Ti (Beckman Instruments, Inc.) 
at 49,000 rpm, The cloudy supernatant was then dialyzed overnight against 
3 changes of 25 mM Tris/1 mM DTT, pH 8.0 (column buffer). The dialyzed 
homogenate was cleared by centrifugation (1 h at 44,000 rpm in a 45Ti ro- 
tor), resulting in ",,900 ml of cleared cytosol. 
Anion Exchange Chromatography on Q Sepharose Fast Flow. 900 ml 
of cytosol was loaded onto a 5  x  10 cm column of Q Sepharose fast flow 
(Pharmacia Fine Chemicals,  Piscataway,  NJ) equilibrated with column 
buffer. Flow rate was 400 ml/h. The column was washed with "~1 column 
volume of column buffer, then two column volumes of column buffer ad- 
justed to 150 mM KCt. The column was then eluted with a linear gradient 
of 150-400 mM KCI in column buffer in a total volume of 2 1.50-ml frac- 
tions were collected. A single activity peak was detected which eluted be- 
twean 200--300 mM KCI with the peak at 250 rnM KC1. A 200-ml lx~ol was 
collected. 
Hydrophobic Chromatography on Phenyl-Sepharose. The Q fast flow 
pool was dialyzed overnight against 25 mM Tris, pH 8.0, 0.7 M ammonium 
sulfate,  10% glycerol,  1 mM DTT. This was loaded onto a 5  x  8.5 cm 
column of phenyl-Sepharose (Pharmacia Fine Chemicals) equilibrated with 
the same buffer. Flow rate was 325 ml/h. The column was washed with one 
column volume of the equilibration buffer and then eluted with a linear gra- 
dient of 0.7-0 M ammonium sulfate and 0-75 % (vol/vol) ethylene glycol, 
10 (vol/vol)-0% glycerol, all in 25 mM Tris, pH 8.0, 1 mM DTT, in a total 
volume of 1 1. 50-ml fractions were collected.  A peak of activity was de- 
tected at 350 mM ammonium sulfate.  Fractions were dialyzed  against 25 
mM Tris, pH 8.0, 1 mM DTT before assay. A 200-mi pool was collected. 
Gel  l~ltraaon  Chromatography  on  Sephadex  G-75. The  phenyl- 
Sepharose pool was concentrated from 200 to 28 ml on an Amicon (Dan- 
vers, MA) stirred concentration cell using a YM-10 membrane. This was 
applied to a 5 x  88 cm column of Sephadex G-75 (Pbarmacia Fine Chemi- 
cals) equilibrated with 25 mM Tris, pH 8.0, 200 mM KCI, I mM UIT. The 
flow rate was 200 ml/h and 50-mi fractions were collected.  A broad peak 
of activity was detected which was centered at an elmion position corre- 
sponding to a globular protein of approximately  35 kD. A 250-ml pool was 
collected. 
Anion Exchange on Mono-Q. The 250-ml G-75 pool was concentrated 
to 35 mi on an Amicon YM-10 membrane and dialyzed overnight with 25 
mM Tris,  1 mM DTT, pH 7.0. This was loaded onto a Mono-Q HR 5/5 
column (Pharmacia Fine Chemicals), equilibrated with 25 mM Tris,  1 mM 
DTT, pH 7.0. The flow rate was 0.3 ml/min. This was washed with 5 ml 
of  equilibration buffer, then 5 mi of equilibration buffer adjusted to 150 mM 
KCI.  Activity  was  eluted with a  gradient of  150-400  mM KC1  in the 
equilibration buffer in a total volume of 20 ml. 0.5-mi fractions were col- 
lected. Activity eluted as a relatively broad peak centered at 250 mM KCI. 
A  1.0-ml pool was made of the active fractions. 
Hydrophobic Chromatography on Propyl-Aspartamide. The Mono-Q 
pool was dialyzed  for 4 h against 25 mM Tris,  1 M ammonium sulfate,  1 
mM IYrT, pH 8.0, and then loaded onto a 4.6 x 200-mm polypropyl Aspar- 
tamide column (The Nest Group,  Southboro,  MA), equilibrated with the 
same buffer used to dialyze the toad. Flow rate was 0.5 ml/min. The column 
was washed with 3 ml of the equilibration buffer and then eluted with a 
simultaneous gradient of 1-0 M ammonium sulfate and 0-50% ethylene 
glycol, both in 25 mM Tris,  1 mM DTT, pH 8.0. 0.5-ml fractions were col- 
lected. Activity eluted at a sharp peak centered at 0.7 M ammonium sulfate. 
Activity  co-eluted with the major protein peak.  A 2.5-ml pool was coI- 
lected. 
Hydroxylapatlte Chromatography. The propyt Aspartamide pool was 
dialyzed overnight against 10 mM KPi, pH 7.0. This was loaded onto the 
HPLC hydroxylapatite  column HCA (7.6 x  100 ram, Rainin Instruments, 
Woburn, MA). Flow rate was 0.5 ml/min. The column was washed with 
3 re./10 mM KPi, pH 7.0, then 3 ml 25 rnM KPi, pH 7.0, and eluted with 
a gradient of 25-70 mM KPi, pH 7.0, in a total volume of 40 ml. Activity 
co-eluted with a protein peak centered at 34 mM KPi. 
Preparation of Crude NSF. Led  crude homogenate prepared as de- 
scribed (Balch et al., 1984a) was centrifuged for 1 h at 100,000 g in a 50ti 
rotor (Beckman Instruments, Inc.). The cloudy supernatant (•8  ml) was 
loaded onto a  1.5  ￿  50 cm column of Sephadex  G-200 (Pharmacia Fine 
Chemicals) equilibrated  and eluted with 20 mM Pipes-KOH (pH 7.0), 2 mM 
Mg2CI2, 2 mM DTT, 0.5 mM ATP and 100 mM KCI. The flow rate was 
50 mi/h. The void peak was collected,  concentrated to 8.0 mi, frozen in liq- 
uid nitrogen, and stored at -80~  before use. 
Electron Microscopy. The visualization of membrane buds and vesicles 
was performed and quantitated as previously described (Hiabsch et al., 
1991). 
Results 
An Assay Measuring Early Events in the Production 
of  Functional Transport Vesicles  Identifies aSNAP as 
a Required Component 
It has previously been shown that primaquine will selectively 
inhibit the production of transport vesicles in a cell-free sys- 
tem  reconstituting  transport  through  the  Golgi  apparatus 
(Hiebsch et al.,  1991). Using this property it was possible 
to construct an assay which measures the cytosolic require- 
ments for vesicle production (Fig.  1). In this assay, donor 
membranes (those which produce transport vesicles contain- 
ing the transported protein VSV G protein) are preincubated 
in  the  presence  of an  ATP  regenerating  system  and  the 
cytosol fractions  to be tested for 20 rain.  During this time 
events in vesicle production take place.  Primaquine is then 
added along with acceptor membranes (the membranes to 
which the vesicles will fuse), an excess of unfractionated 
cytosol and UDP-3[H]-N-acetylglucosamine,  the sugar nu- 
cleotide substrate for the glycosyltransferase  used to mark 
transport of G protein from donor to acceptor.  By adding 
primaquine at the same time as acceptor little new vesicle 
formation  will take place, and therefore  only the influence 
of the cytosol fractions present during the donor preincuba- 
tion  will be measured.  The excess unfractionated cytosol 
will provide the cytosolic requirements  for reactions leading 
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Figure I. The assay for cytosolic factors required for the production 
of functional transport vesicles. In the first stage donor membranes 
are incubated at 37~  (typically for 20 min) with the cytosol frac- 
tion being tested, in addition to an ATP regenerating system and 
buffer. In the second stage primaquine is added (to inhibit further 
vesicle production) as are acceptor membranes and unfractionated 
cytosol (to provide the cytosolic requirements of all transport steps 
subsequent to vesicle production) and UDP-3H-GIcNAc. The as- 
say is then further incubated at 37~  (typically for 90 min) before 
terminating the assay and performing the G protein immunoprecipi- 
tation. 
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Figure 2. (,4) Time course of vesicle production in the primaquine- 
based assay. Donor membranes were incubated for the indicated 
times in the presence ofCHO cytosol (20 #g/ml) and an ATP regen- 
erating system. Acceptor membranes were then added along with 
200/~M primaquine and UDP-[3H]GIcNAc (5/~Ci/ml) and the in- 
cubation was continued for 30 rain before termination and immuno- 
precipitation. (B) The time course of  transport after donor preincu- 
bation in the primaquine-based vesicle production assay. Donor 
membranes were incubated for 15 rain at either 37"C (primed, o) 
or on ice (unprimed, e) with CHO cytosol (40 #g/ml) and an ATP 
regenerating system. Then acceptor membranes were added along 
with 250/zM primaquine and UDP-[3H]GlcNAc  (2.5 izCi/ml). In- 
cubations were continued for the indicated times before termination 
and immunoprecipitation. 
to the fusion of  the transport vesicles. It must be emphasized 
that this assay does not precisely define the events in vesicle 
formation that are being measured; they may include only 
early events, such as the formation of membrane buds, or 
they may include both budding and pinching off of the vesi- 
cles. Further, only functional vesicles will be measured in 
this assay; if nonfunctional vesicle structures are produced, 
these  will  not be  detected.  With  these  characteristics  in 
mind, for simplicity this assay will be referred to as a vesicle 
production assay in the remainder of this report. 
Fig. 2 A illustrates the time course for production of the 
vesicles in the donor preincubation. PQ-resistant transport 
increases linearly with time, reaching a plateau after 15-20 
rain. The time course of glycosylation of G protein after ad- 
dition of acceptor membranes in the secondary incubation 
is shown in Fig. 2 B. As expected, when donor membranes 
are preincubated for 20 min at 37~  (o) there is a large en- 
hancement of the signal produced in comparison with that 
where donor was not preincubated (o). The residual signal 
from unpreincubated donor membranes is probably due to 
a small amount of new vesicle formation initiated in the sec- 
ond incubation. Levels of PQ which completely inhibit vesi- 
cle formation were found to suppress acceptor function as 
well, so the level of PQ was empirically chosen to give the 
largest signal in response to donor preincubation. 
As expected, the vesicle formation assay is cytosol depen- 
dent (Fig. 3 A). Cytosol derived from both CHO ceils (o) 
and bovine brain (e) are quite active, whereas yeast cytosol 
(zx) is only weakly stimulatory. Activity of cytosol is elimi- 
nated by pretreatment of  the cytosol with the alkylating agent 
NEM (Fig. 3 B), indicating that at least one required compo- 
nent is NEM sensitive. 
To focus on the purification of the NEM-sensitive compo- 
nent(s) the assay was modified by the inclusion of NEM- 
treated CHO cytosol in the donor preincubation step. There- 
fore all NEM-resistant components are supplied and only the 
NEM-sensitive component(s) should elicit a response. This 
assay was  applied to fractions derived from fractionation 
of bovine brain cytosol by ion-exchange, hydrophobic, gel 
filtration, and hydroxylapatite chromatographies (see Ma- 
terials and Methods and Fig. 4) and a single peak of activity 
in each column was identified. The activity of this peak was 
completely dependent on the presence of NEM-inactivated 
CHO cytosol (not shown) indicating that vesicle formation 
depends on NEM-resistant cytosolic components in addition 
to the NEM-sensitive activity. This enrichment scheme re- 
suited in the purification of a peptide of 35 kD (Fig. 4). We 
termed this protein PF-1. The specific activity of the purified 
fraction is increased up to 600-fold over that of the starting 
cytosol, although this varied from preparation to prepara- 
tion. The yield of activity is modest, from 0.2-0.5 % of start- 
ing activity. 
PF-1  exhibits two characteristics reminiscent of a previ- 
ously identified transport component, the or-form of  the solu- 
ble NSF attachment protein (otSNAP). First, it elutes from 
the ion exchange resin Q fast flow at 250 mM KCI, as does 
c~SNAP (Clary and Rothman, 1990). Secondly it has a mo- 
lecular mass of 35 kD, similar to ctSNAP. To test the identity 
between PF-I and o~SNAP a protein blot was probed with an 
antipeptide antibody directed against a peptide common to 
c~,/~, but not-ySNAP (Fig. 5). This antibody recognized PF-1 
as well as a  and/~SNAP. PF-1 migrates at the same molecu- 
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Figure 3. Cytosol dependence for the vesicle production assay. (.4) 
Comparison of vesicle production activity of cytosol derived from 
brain (e),  CHO cells (o) and yeast (zx). Protein concentration of 
brain and CHO cytosols was 2.0 mg/ml and yeast cytosol was 4.0 
mg/ml. The background in the absence of added cytosol (234 cpm) 
has been subtracted from each point. (B) CHO cytosol contains an 
NEM-sensitive vesicle production factor(s). CHO cytosol (2 mg/ 
ml) was treated with the indicated levels of NEM for 15 min on ice. 
The NEM was quenched with a twofold excess of DTT before assay. 
10 #1 of treated cytosol was then tested in the assay for vesicle pro- 
duction (o). As a control for the carryover of NEM into the assay, 
one sample was treated first with 2 mM DTT, then 1 mM NEM (e). 
Shown is the mean of duplicate assays. Background in the absence 
of added cytosol (199 cpm) has been subtracted from each point. 
t~gure 4. Purification of  an NEM-sensitive protein required for ves- 
icle production. Samples of pools generated during the purification 
(see Materials and Methods) were separated by SDS-PAGE on a 
15 % acrylamide separating gel as described in Materials and Meth- 
ods.  Lane 1,  crude brain cytosol (20 #g);  lane 2,  pool resulting 
from Q fast flow anion exchange chromatography (20 #g); lane 3, 
pool from phenyl-Sepharose hydrophobic chromatography (20 #g); 
lane 4, pool from sizing on Sephadex G-75 (14 #g); lane 5, pool 
from Mono-Q anion exchange chromatography (8 #g); lane 6, pool 
from propyl-aspartamide hydrophobic chromatography (2 #g); and 
lane 7, pool from HCA HPLC hydroxylapatite chromatography (1.2 
#g). Protein was visualized by silver staining. Migration of molec- 
ular weight standards is indicated on the left. A silver staining arti- 
fact is found to migrate at a molecular mass of 22 kD in all lanes 
containing sample buffer. 
activities are inhibited by NEM treatment,  as is activity in 
the vesicle production  assay (Fig.  6  A).  Interestingly,  how- 
ever, NEM treatment was only partially effective in inhibit- 
ing the ability of PF-1 to mediate NSF binding to membranes 
(Fig. 6 B). This partial NEM sensitivity parallels the ability 
of purified  PF-1  to fully  substitute  for brain  cytosol in the 
NSF binding assay, whereas in both the vesicle production 
and  salt-washed  Golgi  SNAP  assay  the  purified  PF-1  was 
only partially active. We attribute this to some inactivation 
of the PF-1 fraction during purification and believe that this 
data  indicates  that  the  overall  function  of PF-1/SNAP  in 
lar weight as c~SNAP, slightly faster than flSNAP (the addi- 
tional  faster migrating band in the/SSNAP  lane is presum- 
ably a proteolytic product). As expected, the -rSNAP sample 
was not detected  by this antibody. 
PF-1 was also tested in two assays for SNAP function (Fig. 
6). The first of these assays measures the ability of fractions 
to mediate  the binding  of NSF  to membranes  (Fig.  6  B). 
This  was  originally  the  defining  assay  of SNAP  function 
(Weidman et al.,  1989).  A  second assay (Fig. 6  C) relies on 
the observation that SNAP-containing fractions will comple- 
ment a set of partially fractionated cytosolic pools when salt 
washed Golgi membranes are assayed (Clary et al.,  1990). 
In these assays, as well as the vesicle formation assay (Fig. 
6 A) both native (e) and NEM-inactivated  (zx) PF-1 were ti- 
tered as was unfractionated  brain cytosol (o).  PF-1 exhibits 
strong activity in both assays for SNAP  activity,  and those 
Figure 5. PF-1 is immunologi- 
cally  indistinguishable  from 
aSNAP.  100 ng each of PF-1, 
and  or,  /3,  and  ~/SNAP  were 
separated by PAGE, then blot- 
ted  to  nitrocellulose  and 
probed with an antibody raised 
against a peptide common to 
a  and flSNAP,  but lacking in 
-/SNAP. Molecular mass stan- 
dards are shown at the left of 
the blot. Note that PF-1 stains 
equivalently with this antibody 
and comigrates with aSNAP, 
slightly  faster  than  flSNAP. 
As  expected,  no  staining  is 
seen with '},SNAP. The minor staining band in the a  and flSNAP 
lanes is presumably a proteolytic product of the SNAPs. 
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Figure 6. PF-I is active in the SNAP assay for NSF binding and 
the SNAP assay using salt-washed Golgi. The activity of bovine 
brain cytosol (o) (5.4 ~g/ml protein), control PF-1 (I) (10/~g/ml) 
or NEM treated PF-1 (zx) (10/~g/ml) was tested in the primaquine- 
based  vesicle production  assay  (A), the SNAP-dependent NSF 
membrane binding assay (B), or the SNAP-dependent salt-washed 
Golgi assay (C). The primaquine based-vesicle production assay 
(A) was performed as described in Materials and Methods. The 
SNAP-dependent NSF membrane binding assay (B), is a two-stage 
assay. In the first step eytosot fractions are incubated with NSF in 
the presence of membranes depleted of both SNAP and NSE The 
NSF bound to those membranes, as mediated by SNAP activity in 
the cytosol, is then measured in a second, NSF-dependent transport 
assay (see Materials and Methods). The salt-washed Golgi assay 
(C) is based on the observation that when donor and acceptor are 
washed with 1 M KCI, transport is dependent on cytosolic compo- 
nents derived from four separable cytosolic pools. Pool 2 consti- 
tutes SNAP activity, so SNAP activity can be specifically measured 
by assaying salt washed membranes in the presence of pools 1, 3, 
and 4  (see Materials and Methods).  Where indicated PF-1 was 
treated with 0.4 mM NEM on ice for 15 rain, then 0.8 mM DTT 
was added. For control PF-1, the treatments with NEM and 
were reversed. 
transport is more sensitive than that of simply mediating the 
binding of NSF to membranes. 
Taken  together the  immunological and  functional data 
strongly  indicate  that  PF-1  and  aSNAP  are  identical  or 
closely related. This is a surprising result as it has previously 
been suggested that SNAP has a role in membrane fusion, 
not vesicle production. For this reason it was important to 
document  that  the  activity  of PF-1/SNAP  in  the  vesicle 
production assay was in fact due to an action of PF-1/SNAP 
on donor membranes during the vesicle production stage of 
the assay. To eliminate the possibility that activity was some- 
how due to the use of  primaquine to monitor vesicle produc- 
tion, the activity of PF-1/SNAP was measured in the related 
phenomenon of donor "priming" (Fig. 7). It has been shown 
that preincubation of donor (but not acceptor) membranes 
results in a  reduced lag time in the kinetics of G  protein 
transport from donor to acceptor (Balch et al.,  1984b, and 
Fig. 7 A, compare incubations without preincubation of do- 
nor [o] with those including preincubated, "primed" donor 
[e]). This effect requires cytosolic factors and ATP (Balch 
et al., 1984b), and is sensitive to primaquine (Hiebsch et al., 
1991), as is a morphological transformation of donor mem- 
branes resulting in the formation of  membrane buds, the pre- 
sumed precursors of transport vesicles. Priming is therefore 
thought to represent some stages in the formation of trans- 
port vesicles, presumably the same that are measured in the 
assay presented here. No priming was detected in the pres- 
ence of NEM-treated cytosol (Fig. 7 b), however priming 
was restored when PF-1 was added in addition to NEM-in- 
activated cytosol (Fig. 7 c). Clearly PF-1 is acting during the 
priming preincubation, not merely enhancing the activity of 
the assay as a whole. In the latter case priming would have 
been detected with NEM-treated cytosol alone, albeit with 
lower overall counts. Moreover this data illustrates that the 
activity of PF-1/SNAP is not an artifact of the use of prima- 
quine to measure vesicle production. 
This result was  bolstered by testing  whether the  PF-1/ 
SNAP activity could be detected when PF-1ISNAP was added 
after the donor preincubafion step of the primaquine-depen- 
dent vesicle production assay (Fig. 8 A). There was no activ- 
ity when PF-1/SNAP was added after the donor preincuba- 
tion (.) where, as before, activity was observed when it was 
included  during  the  donor  preincubation  (o),  consistent 
with  the  action  of PF-1/SNAP  on  the  donor membranes 
themselves. Furthermore the effect of PF-1/SNAP was only 
observed when it was preincubated with donor membranes 
(Fig. 8 B, o) and not acceptor membranes (Fig. 8 B, e) il- 
lustrating that there is not simply a requirement that PF-I! 
SNAP be preincubated with a membrane fraction to exhibit 
activity. 
NSF Is Required during Vesicle  Formation and 
the NEM-sensitive Function of  NSF Is Fulfilled by 
Interaction with Donor Membranes 
Because the function of the SNAP is to mediate the binding 
of NSF to Golgi membranes (Weidman et al.,  1989), it was 
of interest to test whether NSF was also required in the vesi- 
cle formation assay.  Fig. 9 shows that if NSF is inactivated 
with NEM before the donor incubation, no activity is ob- 
served, even when NSF is included in the second-stage incu- 
bation of the assay (e). Addition of NSF to the donor prein- 
cubation,  however, completely restores activity (o).  This 
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Figure 7. PF-1 activity is required  in a nonprimaquine-based, ki- 
netic assay for the formation of functional vesicles.  Donor mem- 
branes were first incubated for 20 rain at either 37~  (primed)  (e) 
or 4"C (unprimed) (o) in the presence of either 10 #g of untreated 
CHO cytosol (a), 10/~g of NEM-treated CHO cytosol (b) or 10/zg 
of NEM-treated cytosol plus 4 #g of partially purified PF-1 (pool 
from the Q fast flow column, see Materials and Methods). Acceptor 
membranes and UDP-3H-GIcNAc  were then added and the incu- 
bations were continued for the indicated times before removing ali- 
quots and freezing on dry ice. At the conclusion of the time course 
all samples were thawed and immunoprecipitated together.  To the 
incubations  depicted in b and c,  10 #g of untreated  CHO cytosol 
was also added after the donor preincubation. 
demonstrates that the NEM-sensitive function of NSF is re- 
quired for the formation of functional vesicles in this assay. 
To test whether the NEM-sensitive function of NSF is also 
required  for fusion of transport  vesicles  (Fig.  10),  donor 
membranes were preincubated to allow events in vesicle for- 
marion to occur. After various intervals the endogenous NSF 
was inactivated by NEM treatment for 5 min at 37~  The 
NEM  was  then  quenched  with  DTT  and  acceptor  mem- 
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Figure 8. (A) PF-1 is active when added during the donor prcincu- 
bation, but not afterwards,  in the primaquine-based vesicle produc- 
tion assay. Donor membranes were first  incubated  for 20 rain at 
37"C with  10 /zg of NEM-treated CHO cytosol. Then acceptor 
membranes were added along with  10 #g of unfractionated CHO 
cytosol primaquine, and UDP-3H-GIcNAc and the incubation was 
continued for 90 min before termination of  the assay. The indicated 
amounts of PF-1 were added either during the donor preincubation 
(o), or in the second stage, postprimaquine incubation (e). Shown 
is the average of  triplicate samples for each point. (B) PF-1 is active 
when preincubated with donor but not acceptor membranes in the 
primaquine-based  vesicle  production assay.  The assay  was  per- 
formed as described in Materials  and Methods with the modifica- 
tion that in one set of assays  (e) acceptor membranes were sub- 
stituted for donor membranes in the first preincubation. A second 
set (o) was assayed exactly as described, using donor in the first 
stage preincubation.  Purified PF-1 (270 ttg/ml) was added in the in- 
dicated  amounts. 
branes (pretreated with NEM to inactivate endogenous NSF) 
were added along with cytosol and UDP-[3H]-GIcNAc and 
the incubation was continued to allow transport.  Note that 
primaquine is not used in this experiment.  Preincubation of 
donor membranes (Fig. 10, e) followed by NEM inactivation 
results in transport that is identical to the addition of exoge- 
nous NSF to membranes treated with NEM without preincu- 
bation (open circle on ordinate). In these experiments the do- 
nor membranes were continuously held at 37~  It was found 
that NEM-resistant activity was lost if the donor membranes 
were placed on ice after preincubation (data not shown). In 
contrast  to  the  results  obtained  with  donor  membranes, 
preincubation of acceptor membranes (A), followed by the 
addition  of NEM  pretreated  donor membranes,  does  not 
yield NEM-resistant  transport activity.  This striking result 
directly  demonstrates  that  the  NEM-sensitive  function  of 
NSF is  no longer required  once steps  in the  formation of 
transport vesicles have occurred. 
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Figure 9.  NSF is active when added during the donor preincuba- 
tion, but not afterwards,  in the primaquine-based  vesicle produc- 
tion assay. Donor membranes (treated with 1 mM NEM on ice for 
15 min, the 2 mM DTT) were first incubated for 20 rain at 37~ 
with 10 #g of NEM-treated CHO cytosol (priming). Then acceptor 
membranes (treated with NEM in the same manner as the donor) 
were  added  along  with  10  #g of unfractionated  CHO cytosol, 
primaquine,  and  UDP-3H-GlcNAc and  the  incubation  was con- 
tinued for 90 min before termination  of the assay. The indicated 
amounts of crude NSF (see Materials and Methods) were added ei- 
ther during the donor preincubation  (o), or in the second stage, 
postprimaquine  incubation (￿9 
Vesicle~Bud Structures Are Produced in the 
Absence of SNAP 
Because the experiments described above measure the for- 
mation of vesicles by a functional criteria it was important 
to determine whether the formation of vesicle structures also 
requires SNAP. After incubation under the appropriate con- 
ditions Golgi preparations were visualized by EM (Fig.  11) 
and the formation of membrane buds, which are thought to 
be the precursors to transport vesicles (Balch et al.,  1984b; 
Orci et al.,  1986,  1989), were quantitated (Fig.  12).  Donor 
membranes were incubated either on ice (Fig.  12 A) or at 
37~  (Fig.  12,  B-E),  with complete cytosol (Fig.  12 B), 
NEM-treated  cytosol to  deplete  PF-1/SNAP  (Fig.  12  C), 
NEM-treated cytosol plus PF-1/SNAP (Fig.  12 D), or with- 
out cytosol (Fig.  12 E).  Relatively few buds/vesicles were 
found when the membranes were incubated on ice or without 
cytosol, as previously reported (Balch et al.,  1984b).  The 
number of buds/vesicles produced did not appear to depend 
on the presence of PF-1/SNAP as similar numbers were noted 
with untreated cytosol and NEM-treated cytosol. These data 
indicate that whereas SNAP and NSF appear to be required 
for the formation of functional vesicles, nonfunctional vesi- 
cle structures may still be manufactured in the absence of 
SNAP and NSE  It is also formally possible that buds are 
formed, but that SNAP and NSF are required for the pinch- 
ing  off of those  buds  to  produce  fully  formed  transport 
vesicles. 
￿9 
40O 
z 
Ld 
z 
i  200q 
o_ 
0  I  L  I  I 
0  5  10  15  2O 
TIME  OF  PRE-INCUBATION  BEFORE  NEM  (MIN) 
Figure 10.  Preincubation  of donor membranes,  but not acceptor 
membranes, renders subsequent transport resistant to NEM inacti- 
vation of NSE  Donor (￿9  or acceptor membranes (A) were in- 
cubated with brain cytosol and the ATP regenerating mix for the 
indicated times at 37~  NEM was then added to each tube to a final 
concentration  of 0.5 mM and the incubation was continued for 5 
min. Then each tube received a mixture of 5/~1 of brain cytosol and 
5 #1 of either acceptor membranes (in the case of preincubated do- 
nor membranes) or donor membranes (in the case of preincubated 
acceptor membranes),  DTT to a final concentration of 1 mM and 
3H-UDP-GlcNAc.  Membranes  added  at  this  stage  had  been 
pretreated  with  NEM (Glick  and  Rothman,  1987) to inactivate 
NSF. The incubation was then continued for 60 min before termina- 
tion and immunoprecipitation.  For comparison,  to one sample of 
donor membranes that were NEM treated without preineubation, 
5 #1 of crude NSF (see Materials  and Methods) was added (o). 
Results are the average of duplicate samples. 
Discussion 
The data presented here indicate that two proteins,  SNAP 
and  NSF,  which  had previously been thought to function 
during vesicle fusion steps of transport, are required during 
the formation of functional transport vesicles. Initially, we 
arrived at this conclusion by the use of an assay which mea- 
sures the activity in driving donor membranes, the mem- 
branes which produce transport vesicles in this assay, into 
a primaquine-resistant state. We also used a kinetic "prim- 
ing"  assay,  in  which  preincubation  of donor  membranes 
reduces the lag time of transport to acceptor membranes. 
The supposition that these assays measure events in the for- 
mation of transport vesicles is based on the observation that 
both types of transformation (primaquine resistance, and ki- 
netic alterations) are dependent on ATP and cytosol, as is the 
morphological appearance of membrane buds, the presumed 
precursors of transport vesicles (Balch et al., 1984b; Orci et 
al.,  1986).  In  addition,  a  priori  reasoning  suggests  that 
events in vesicle production are being affected because these 
alterations are occurring in donor membranes, whose sole 
function  in  the  transport  system is  to  produce  transport 
vesicles. 
These conclusions were strongly supported by the striking 
observation that after preincubation of donor (but not accep- 
tor) membranes the NEM-sensitive function of NSF is no 
longer  required  to  drive  transport  (Fig.  10).  This  result 
demonstrates that NSF must interact specifically with donor 
membranes  to  perform its  function,  and  that  the  NEM- 
sensitive portion of that function is complete after that inter- 
action. The most plausible explanation for this result is that 
NSF  is required  for the formation of functional transport 
The Journal of Cell Biology, Volume  ll8,  1992  1328 Figure 11. The structural formation of buds/vesicles does not depend on PF-1/SNAP. Transport reactions were incubated for 20 min either 
at 4~  (A) or 37~  (B-E). The cytosol additions were: unfractionated,  0.5 mg/rnl untreated CHO cell cytosol (A and B), 0.5 mg/ml NEM- 
treated CHO cytosol (PF-1/SNAP deficient) (C), 0.5 mg/ml NEM-treated CHO cytosol plus 58/~g/ml partially purified PF-1/SNAP (through 
Mono-Q)  (D), no cytosol (E). The samples were then processed  for EM as described  in Materials  and Methods. 
vesicles.  This was an unexpected  finding  as the  ability of 
preincubation of donor and acceptor membranes to fulfill 
NSF function had been tested previously (Malhotra et al., 
1988), and no such effect had been found. This inconsistency 
is explained by a crucial technical difference between the two 
experiments.  In retesting the conditions used by Malhotra 
and colleagues, where the NEM treatment was performed on 
ice after membrane incubation,  we found that cooling the 
membranes resulted in a loss of NEM resistance (data not 
shown). In contrast, our NEM treatments were performed at 
37~  and the membranes were never cooled.  Apparently 
whatever function is performed by NSF in the donor mem- 
branes is reversed by incubation at low temperature. 
Previous models suggesting a role for NSF and SNAP in 
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Figure 12. Quantitation of bud/vesicle formation in the presence and absence of PF-1/SNAP. Micrographs resulting from transport reactions 
corresponding to those shown in Fig.  11 were quantitated for the formation  of buds and/or vesicles as described  (Hiebsch et al.,  1991). 
(a) Unfractionated  CHO cytosol, incubation at 4~  (b) Unfractionated  CHO cytosol, incubation at 37~  (c) NEM-treated  CHO cytosol 
(PF-1/SNAP  deficient).  (d) NEM-treated CHO cytosol plus partially purified PF-1/SNAP  (purified through Mono-Q). (e) No cytosol. De- 
tails of transport reactions  are given in the legend to Fig.  11. Histograms were constructed  by counting  individual  Golgi complex areas 
and dividing the total number of buds/vesicles counted by the area counted. Each Golgi apparatus counted was then placed into a density 
class.  The results are expressed as percentage  of total Golgi complexes to compensate for the unequal  number of Golgi complex areas 
counted in the different samples.  Number of Golgi complexes counted were:  a, 34; b, 56; c, 44; d, 56; and e, 49. 
The  Journal  of Cell  Biology,  Volume  118,  1992  1330 vesicle attachment and/or fusion are based on studies both 
in mammalian and yeast systems. When NSF was inactivated 
by NEM treatment in the mammalian Golgi transport sys- 
tem, the morphological accumulation of attached vesicles 
was noted (Malhotra et al., 1988; Orci et al., 1989). The in- 
capacitation of the yeast SNAP and NSF homologues Secl7 
and Secl8 by mutation results in the accumulation of free 
transport vesicles in vivo (Kaiser and Schekman, 1990).  In 
a permeabilized yeast ER to Golgi transport system, inacti- 
vation of the secl8 gene product by mutation also leads to 
the  accumulation of free  transport  vesicles  (Rexach  and 
Schekman, 1991). These data are consistent with our finding 
that the absence of  PF-1/SNAP does not impair the formation 
of membrane buds as quantified by EM. Although each of 
these results indicate that the formation of vesicle structures 
does not depend on SNAP or NSF function, the functionality 
of the vesicles produced was not ascertained. 
The simplest model reconciling these data is that SNAP 
and NSF are required during vesicle formation because they 
become incorporated into the vesicle membrane. These pro- 
teins would then be ferried on the vesicles to the fusion site 
where  they would  perform  a  role  in  vesicle  attachment 
and/or fusion. This could be a  mechanism to ensure that 
these proteins are specifically targeted to the fusion sites. It 
should be noted that in an assay measuring fusion of endo- 
cytic vesicles (a situation in which vesicle formation has al- 
ready  occurred)  NSF  can  be  added  to  NEM-inactivated 
membranes to restore fusion activity (Diaz et al.,  1989), 
whereas in our assays we could not detect activity when 
SNAP or NSF were added after the vesicle formation step. 
This may be due to differences between endocytic fusion and 
transit through the Golgi, or may indicate that with appropri- 
ate  experimental  manipulations  SNAP  and  NSF  can  be 
forced to bind to vesicles after their formation. However 
since SNAP and NSF are always present in the cytosol, and 
thus available during vesicle formation, this is unlikely to be 
physiologically relevant. One implication of this scheme is 
that the incorporation of NSF into forming vesicles is NEM 
sensitive, whereas the attachment/fusion function of NSF is 
not. In fact, a recent report indicates that the NEM treatment 
of NSF cripples its ability to bind to the SNAP/membrane 
receptor complex (Wilson et al., 1992). The binding of NSF 
and SNAP to forming vesicles followed by their action at the 
site of fusion is similar to a model proposed for the cycling 
of small molecular weight GTP binding proteins that act in 
vesicular transport (Bourne, 1988).  Morphological and bio- 
chemical data indicate that Sec4p,  a yeast GTP binding pro- 
tein required for vesicle fusion to the plasma membrane, is 
incorporated into the vesicle membrane and then released af- 
ter successful delivery of the vesicle to its target site (Goud 
et al.,  1988). 
One interesting observation from this work is that SNAP 
function is sensitive to alkylation by NEM, but that the de- 
gree of NEM sensitivity is dependent on the assay used to 
measure SNAP function. In an assay measuring the ability 
of SNAP to mediate the binding of NSF to the membrane 
binding sites (Fig. 6 B) NEM only partially inactivated PF- 
1/SNAP. However in a transport assay where SNAP is re- 
quired to complement other cytosolic pools as well as in the 
vesicle production  assay,  SNAP  activity was  completely 
eliminated by NEM treatment. This indicates that SNAP has 
a catalytic function in transport that goes beyond its ability 
simply to mediate NSF binding. Such a view supports an 
earlier contention that SNAP functions with NSF as part of 
a multisubunit functional particle (Malhotra et al.,  1988). 
The assertion that the Golgi protein transport assay mea- 
sures vesicular transport has recently come under scrutiny. 
It has been suggested, for example, that the system measures 
"homotypic" fusion, that is, the fusion between the medial- 
cisternae of donor and acceptor membranes (Mellman and 
Simons,  1992).  We show here that there are very specific 
conditions of preincubation of donor but not acceptor mem- 
branes which confer a number of special properties to subse- 
quent transport (i.e., primaquine resistance and NEM resis- 
tance).  Quite apart from the morphological examinations 
that have been performed on this system, this asymmetry is 
a strong biochemical argument that vesicular transport is in- 
deed occurring in this assay. If the transport was simply due 
to cisternal fusion, then there would be no differentiation  be- 
tween donor and acceptor membranes. We therefore believe 
that results derived from the Golgi transport assay can be 
reliably interpreted as reflecting vesicular transport. As ex- 
emplified by the unexpected findings we have reported here, 
the primaquine-based vesicle production assay should prove 
to be a very useful tool in examining the biochemical mecha- 
nisms of vesicle production and function. 
We would like to thank Dr. W. Whiteheart and Dr. J. Rothman for gener- 
ous gifts of purified SNAPs and antiserum to the SNAPS, as well as for 
helpful comments. We are grateful to Dr. P. Melangon for insightful com- 
ments about this work.  L.  Lecureux carefully prepared the membranes 
used in this investigation, and G. Sawada provided excellent assistance with 
EM. 
P. J. Weidman was supported by American Cancer Society grant BE-87. 
Received for publication 6 September 1991  and in revised form 17 June 
1992. 
References 
Balch, W. E.  1989.  Biochemistry of interorganelle transport. A new frontier 
in enzymology emerges from versatile in vitro  model systems. J.  Biol. 
Chem.  264:16965-16968. 
Balch, W. E., W. G. Dunphy, W. A. Braell, andJ. E. Rothman. 1984a. Recon- 
stitution of the transport of protein between successive  compartments of the 
Golgi measured by the coupled incorporation of N-aeetylglucosamine. Cell. 
39:405--416. 
Balch, W. E., B. S. Glick, and J. E. Rothman. 1984b. Sequential intermediates 
in the pathway of intercompartmental transport in a cell-free system. Cell. 
39:526-536. 
Block, M. R., B. S. Glick, C. A. Wilcox, F. T. Wieland, and J. E. Rothman. 
1988. Purification  of  an N-ethylmaleimide-sensitive  protein catalyzing vesic- 
ular transport. Proc. Natl. Acad.  Sci.  USA.  85:7852-7856. 
Bourne, H.  R.  Do GTPases direct membrane traffic  in secretion? Cell.  53: 
669-671. 
Clary, D. O., and S. E. Rothman. 1990. Purification  of three related peripheral 
membrane proteins needed for vesicular transport.  J.  Biol.  Chem.  265: 
10109-10117. 
Clary, D. O., I. C. Griff, and J. E. Rothman. 1990. SNAPS, a family of NSF 
attachment proteins involved in intracallular membrane fusion in animals 
and yeast. Cell.  61:709-721. 
Diaz, R., L. S. Mayorga, P. J. Weidman, J. E. Rothman, and P. D. Stahl.  1989. 
Vesicle fusion following receptor-mediated endocytosis requires a protein 
active in Golgi transport. Nature (Land.).  339:398-400. 
Fries, E., and J. E. Rothman. 1980. Transport of vesicular stomatitis virus gly- 
coprotein in a cell-free extract. Proc. Natl. Acad. Sci.  USA. 77:3870-3874. 
Glick, B. S., and J. E. Rothman. 1987.  Possible role for fatty acylcoenzyme 
A in intracellular protein transport. Nature (Land.).  362:309-312. 
Goda, Y., and S. R. Pfeffer.  1989. Cell-free systems  to study vesicular transport 
along the secretory and endoeytic pathways. FASEB (Fed. Am. Sac.  Exp. 
Biol.) J.  3:2488-2495. 
Goud, B., A. Salminen, N. C. Walworth, and P. J.  Novick.  1988.  A GTP- 
Wattenberg et al.  Formation of Active Golgi Transport Vesicles  1331 binding protein required for secretion rapidly associates with secretory vesi- 
cles and the plasma membrane in yeast. Cell.  53:753-768. 
Hicke, L., and R. Schekman. 1990. The molecular machinery required for pro- 
tein transport from the endoplasmic reticulum to the Golgi complex. Bioas- 
says.  12:253-258. 
Hiebsch, R. R., T. J. Ranb, and B. W. Wattenberg. 1991. Primaquine blocks 
transport by inhibiting the formation of functional transport vesicles; studies 
in a celt free assay of protein transport through the Golgi. J.  Biol.  Chem. 
266:20323-20328. 
Kaiser, C. A., and R. Schekman. 1990. Distinct sets of SEC genes govern trans- 
port  vesicle formation and  fusion early  in the secretory pathway.  Cell. 
61:723-733. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage 1"4. Nature  (Lond.).  227:680-685. 
Malhotra, V., L. Orci, B. S. Glick, M. R. Block, and J. E. Rothman. 1988. 
Role of an N-ethylmaleimide-sensitive transport component in promoting 
fusion of transport vesicles with cisternae of the Golgi stack.  Cell.  54: 
221-227. 
Melan~on, P., B. S. Glick, V. Malhotra, P. J. Weidman, T. Serafini,  M. L. 
Gleason, L. Orci, and J. E. Rothman. 1987.  Involvement of GTP-binding 
"(3' proteins in transport through the Gotgi stack. Cell.  51:1053-1062. 
Metlman, I., and K. Simons. 1992. The Golgi Complex: In Vitro Veritas? Cell. 
68:829-840. 
Orci, L., B. S. Glick, and J. E~ Rothman. t986. A new type of coated vesicular 
carrier that appears not to contain clathrin: its possible role in protein trans- 
port within the Golgi stack. Cell.  46:t71-184. 
Orci, L., V. Malhotra, M. Amherdt, T. Serafini, andJ. E. Rothman. 1989. Dis- 
section of a single round of vesicular transport: sequential coated  and un- 
coated intermediates mediate intercisternal movement in the Golgi stack. 
Cell.  56:357-368. 
Rexach, M. F., and R. W. Schekman. 1991. Distinct biochemical requirements 
for the budding, targeting, and fusion of ER-derived transport vesicles. J. 
Celt BioL  114:219-229. 
Rothman, J. E., and L. Orci. 1992. Molecular dissection of the secretory path- 
way. Nature  (Lond.).  355:409--415. 
Rothman, L  E., L. J. Urbani, and R. Brands. 1984.  Transport of protein be- 
tween cytoplasmic membranes of fused ceils: correspondence to processes 
reconstituted in a cell-free system. J.  Cell BioL  99:248-259. 
Schekman, R. 1985. Protein localization  and membrane traffic in yeast. Annu. 
Rev.  Cell Biol.  1:115-143. 
Stanley, P., S. Narasimhan, L. Siminovitch, and H. Schachter. 1975. Chinese 
hamster ovary ceils selected for resistance to the cytotoxicity of  phytohemag- 
glutinin are deficient in a UDP-N-acetylglucosamine-glycoprotein,  N-acetyl- 
glucosaminyltransferase activity.  Proc.  Natl.  Acad.  Sci.  USA.  72:3323- 
3327. 
Wattenberg, B.  W.  1990.  The molecular control of transport vesicle fusion. 
New Biol.  2:505-511. 
Wattenberg, B. W., W. E. Balch, L  E. Rothman. 1986. A novel prefusion of 
complex formed during protein transport between Golgi cisternae in a cell- 
free system. J.  Biol.  Chem.  261:2202-2207. 
Wattenberg, B. W., R. R. Hiebsch, L. W. Lecureux, and M. P. White. 1990. 
Identification  of a 25-kD protein from yeast cytosol that operates in a prefu- 
sion step of vesicular transport between compartments of the Golgi. J. Cell 
Biol.  110:947-954. 
Weidman, P. J., P. Melanqon, M. R. Block, andJ. E. Rothman, 1989. Binding 
of an NEM-sensitive fusion protein to Golgi membranes  requires both a solu- 
ble protein(s) and an integral membrane receptor. J.  Cell Biol.  108:1589- 
1596. 
Wilson, D. W., S. W, Whiteheart, M. Wiedmann, M. Brunner, and J. E. Roth- 
man. 1992. A multisubunit particle implicated in membrane fusion, J,  Cell 
Biol.  117:531-538. 
The Journal of Cell Biology, Volume 118,  1992  1332 